NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 15 filers reported holding NEURODERM LTD in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $14,109,000 | +64031.8% | 362,703 | +50345.5% | 0.01% | – |
| Q2 2017 | $22,000 | +22.2% | 719 | -11.7% | 0.00% | – |
| Q4 2016 | $18,000 | -72.3% | 814 | -76.7% | 0.00% | – |
| Q3 2016 | $65,000 | +54.8% | 3,492 | +35.2% | 0.00% | – |
| Q2 2016 | $42,000 | -28.8% | 2,582 | -38.2% | 0.00% | – |
| Q1 2016 | $59,000 | +9.3% | 4,176 | +30.1% | 0.00% | – |
| Q4 2015 | $54,000 | – | 3,211 | +64120.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 5 | -96.7% | 0.00% | – |
| Q2 2015 | $2,000 | 0.0% | 151 | -13.7% | 0.00% | – |
| Q1 2015 | $2,000 | -85.7% | 175 | -82.5% | 0.00% | – |
| Q4 2014 | $14,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 327,240 | $9,784,000 | 4.26% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,383,358 | $131,062,000 | 2.70% |
| SENZAR ASSET MANAGEMENT, LLC | 357,400 | $10,686,000 | 2.63% |
| Rhenman & Partners Asset Management AB | 461,654 | $13,803,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 168,025 | $5,007,000 | 1.90% |
| GREAT POINT PARTNERS LLC | 311,000 | $9,299,000 | 1.67% |
| Opaleye Management Inc. | 120,300 | $3,597,000 | 1.50% |
| SECTORAL ASSET MANAGEMENT INC | 350,085 | $10,468,000 | 1.14% |
| MENORA MIVTACHIM HOLDINGS LTD. | 808,073 | $24,161,000 | 1.13% |
| Redmile Group, LLC | 555,096 | $16,597,000 | 1.01% |